Osteoporosis in over 50s - clinical fact sheet and MCQ
Overview
Osteoporosis is a systemic skeletal disease defined by reduced bone mineral density (BMD) and microarchitectural deterioration, increasing the risk of fractures.1,2 It is a major public health issue, affecting millions of Australians over 50 years of age. The condition is largely asymptomatic until a fracture occurs, leading to underdiagnosis and undertreatment.1
Fractures related to osteoporosis, particularly hip and vertebral fractures, are associated with increased mortality and morbidity, loss of independence and quality of life. There is insufficient evidence to recommend population-based systematic screening with BMD measurement for reduction of osteoporotic fractures in Australia, and case-finding is recommended, including with the use of a fracture risk assessment tool, particularly the Fracture Risk Assessment Tool, FRAX®.
Assessing risk of osteoporosis
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreMedcast Medical Education Team
Age-related macular degeneration (AMD) causes half of all blindness and severe vision loss among older Australians. Though there is currently no definitive cure, early identification and intervention can help to slow disease progression and preserve sight. This FastTrack highlights the role of GPs in recognising AMD, providing primary care interventions, and when to refer.
Medcast Medical Education Team
The management of chronic hepatitis C infection can be challenging. This FastTrack discusses when and how to screen, indications for urgent specialist referral, and the use of direct-acting antiviral medications. 30mins RP and 30mins EA CPD are available with the quiz.
Medcast Medical Education Team
Metabolic dysfunction-associated fatty liver disease affects up to 30% of adults worldwide. Find out more about this progressive liver condition with this FastTrack fact sheet, which covers diagnosis to management, including lifestyle and pharmacological interventions for primary practice. 30mins each of RP and EA CPD available with the quiz.
